• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Vaccines

$3,500.00 – $7,000.00

Clear
SKU: KLI1005787 Categories: Pharmaceuticals Market Research, Vaccines Market Reports Pages: 296
  • Description
  • Table of Contents
  • Latest reports

Description

This report covers pediatric and adult preventive vaccine products and provides an analysis of therapeutic vaccines for cancer treatment. In assessing the market for vaccine products, Kalorama Information provides sales data for the 2001-2003 historical years, the 2004 base year, and the 2001 through 2010 forecast years. Revenues are expressed in terms of manufacturers’ annual sales and in current U.S. dollars.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and e-mail correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

Pediatric vaccines include the following:

  • Combination vaccines
  • Diphtheria-tetanus-pertussis (DTP) and diphtheria-tetanus-acellular pertussis (DTaP)
  • Hepatits A; Hepatitis B
  • Measles-mumps-rubella (MMR)
  • Pneumococcal
  • Poliovirus
  • Varicella
  • Others

Adult vaccines include the following:

  • Hepatitis A; Hepatitis B
  • Influenza
  • Pneunomoccal
  • Travel; DT; others

In addition to preventive vaccines, the emerging area of therapeutic vaccines for the treatment of cancer is covered, including current revenues from the handful of products now on the market, plus a forecast of revenues for products likely to see approval through 2008.

Table of Contents

Chapter One: Executive Summary

Scope and Methodology

Size and Growth of the Market

Market Trends

Industry Structure and Leading Competitors

Chapter Two: Introduction to Vaccines

A Brief History:  The Development of Vaccines

The Immune Response

Mechanism of Action

Types of Vaccines

Attenuated (Weakened) Live Viruses

Killed Whole Vaccines

Toxoid Vaccines

Genetically Engineered/Modified Vaccines

Subunit Vaccines

Conjugate Vaccines

Vaccine Approval Process

DNA Vaccines

Mechanism of Action of DNA Vaccines

Advantages of DNA Vaccines

Therapeutic Vaccines to Treat Cancer

Chapter Three: Pediatric Preventive Vaccines

Overview

Childhood Immunization in the United States

Childhood Immunization Rates

Challenges to the Vaccine Delivery System

Recommended Childhood Immunization Schedule

 

Pediatric Vaccine Products

BCG Vaccines

Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Vaccines

Diphtheria

Pertussis

Tetanus

Hepatitis B

Poliomyelitis

Haemophilus Influenzae Type B Vaccines

Hepatitis A Vaccines

Measles, Mumps and Rubella Vaccines

Measles

Mumps

Rubella

Pneumococcal Conjugate Vaccine

Rotavirus Vaccines

Varicella Vaccines

Cost of Vaccines in the United States

Pediatric Vaccines in Development

Global Initiatives for Vaccine Research

Diarrhea-Related Diseases

Rotavirus

Rotavirus Vaccines

Rotavirus Vaccines in Clinical Trials

Enterotoxigenic Escherichia coli

ETEC Vaccines in Clinical Trials

Acute Respiratory Infections

Streptococcus Pneumoniae

Pneumococcal Vaccines

Respiratory Syncytial Virus

RSV Vaccines in Clinical Trials

Parainfluenza Virus Type 3

PIV-3 Vaccines in Clinical Trials

The World Market for  Pediatric Preventive Vaccines

Total Market Size and Forecast

DTP and DTaP Vaccine Market

Market Analysis

Leading Products and Competitors

Hepatitis Vaccine Market

Market Analysis

Leading Products and Competitors

Haemophilus Influenzae Type B Vaccine Market

Market Analysis

Leading Products and Competitors

Measles, Mumps and Rubella Vaccines

Market Analysis

Leading Products and Competitors

Combination Vaccines Market

Market Analysis

Leading Products and Competitors

Pneumococcal Vaccine

Market Analysis

Poliovirus Vaccine

Market Analysis

Leading Products and Competitors

Varicella Vaccines

Market Analysis

Leading Products and Competitors

Other Vaccines Market

Market Analysis

Leading Products and Competitors

Chapter Four: Adult Preventive Vaccines

Introduction

Adult Vaccine-Preventable Diseases: Facts and Figures

Global Virological Surveillance Program

Recommendations for Adult Immunizations

Vaccine Recommendations for International Travel

CDC’s Revised Recommendations for Influenza Vaccination for 2004-05 Flu Season

Priority Groups for Influenza Vaccination

Other Vaccination Recommendations

Vaccination of Persons in Nonpriority Groups

Persons Who Should Not Receive Influenza Vaccine

CDC’s Recommendations for Yellow Fever Vaccination

WHO International Health Regulations

Adult Vaccine Products

BCG Vaccines

Cholera Vaccines

Diphtheria-Tetanus Vaccines

Hepatitis Vaccines

Hepatitis A

Hepatitis B

Influenza Vaccines

Japanese Encephalitis Vaccine

 

Pneumococcal Disease Vaccines

Rabies Vaccine

Typhoid Vaccines

Yellow Fever Vaccines

Adult Vaccines in Development

Global Initiatives for Vaccine Research

Cholera Vaccines

Dengue Fever Vaccines

Epstein-Barr Virus Vaccines

HIV/AIDS

AIDS Vaccines

Helicobacter Pylori Vaccines

Hepatitis Vaccines

Hepatitis C

Hepatitis E

Herpesvirus Vaccines

Leishmaniasis

Severe Acute Respiratory Syndrome

Shigella Vaccine

West Nile Virus

The World Market for Adult Preventive Vaccines

Total Market Size and Forecast

Hepatitis Market

Market Analysis

Leading Products and Competitors

Influenza Vaccine Market

Market Analysis

Leading Products and Competitors

Pneumococcal Vaccine Market

Market Analysis

Leading Products and Competitors

Travel; DT; Miscellaneous Market

Market Analysis

Leading Products and Competitors

Chapter Five: Preventive Vaccines Market Summary

Trends Driving the Preventive Vaccines Market

Market Size and Forecast

Vaccine Market Competitors

Pediatric Vaccines

Major Manufacturer’s Market Share

Adult Vaccines

Major Manufacturer’s Market Share

 

Chapter Six: Therapeutic Cancer Vaccines

Cancer Vaccine Technology

Cancer Statistics

Available Cancer Vaccines

Bladder Cancer

Colorectal Cancer

Melanoma

Types of Cancers Susceptible to Vaccines

Breast Cancer

Cervical Cancer

Colorectal Cancer

Gastrointestinal Cancer

Stomach

Liver

Pancreas

Kidney

Leukemia

Lung Cancer

Lymphoma

Melanoma

Multiple Myeloma

Neuroblastoma

Ovarian Cancer

Prostate Cancer

Sarcoma

Cancer Vaccine Pipeline

Vaccine Candidates in Phase III

Vaccine Candidates in Phase II

Vaccine Candidates in Phase I

The Emerging Cancer Vaccine Market

Total Market Size and Forecast

Competitor Analysis

Chapter Seven: Issues and Trends

Vaccine Safety

Pre-licensure Evaluation

Post-Licensure Surveillance

Vaccine Adverse Event Reporting System

The Vaccine Safety Datalink Project

The Vaccine Injury Compensation Program

The Future of Vaccine Safety

Vaccine Shortages

Preventing Future Shortages in the U.S.

Financial incentives

Equitable pricing

Utilizing vaccine stockpiles

Impact of Product Divergence on Vaccine Supply in Developing Countries

Vaccines and Bioterrorism

Overview

Project Bioshield Act of 2004

Anthrax

Smallpox

Plague

Botulism

Tularemia

Viral Hemorrhagic Fevers

Innovations in Vaccine Delivery Systems

Edible Vaccines

Mucosal Delivery

Intranasal Delivery

Oral Vaccines

Vaccine Patches

Chapter Eight: Company Profiles

Acambis plc

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

AlphaVax, Inc.

History and Lines of Business

Strategic Alliances

Vaccine Products

Avant Immunotherapeutics

History and Lines of Business

Strategic Alliances

Vaccine Products

Aventis Pasteur

History and Lines of Business

Strategic Alliances

Vaccine products

Financial Information

 

Bavarian Nordic A/S

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Baxter Healthcare

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Berna Biotech AG

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

BioPort Corporation

History and Lines of Business

Strategic Acquisition and Alliance

Vaccine Products

Chiron Corporation

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Corixa Corporation

History and Lines of Business

Strategic Alliances

Vaccine Products

Epimmune, Inc.

History and Development

Corporate Contract with NIH

Vaccine Products

GlaxoSmithKline

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

ID Biomedical Corporation

History and Lines of Business

Vaccine Products

MedImmune, Inc.

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Merck & Co Inc

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Nabi Biopharmaceuticals

History and Lines of Business

Strategic Alliance

Vaccine Products

Financial Information

Vical Incorporated

History and Lines of Business

Strategic Alliances

Technology Platform

Therapeutic Cancer Vaccine Products in Clinical Trials

Financial Information

Wyeth

History and Lines of Business

Vaccine Products

Financial Information

Appendix A: Vaccine Products

Appendix B: Company Directory

 

list of exhibits

Chapter One: Executive Summary

Table 1-1: Impact of Vaccines in the 20th Century

Table 1-2: The World Vaccines Market by Vaccine Target 2001-2005

Figure 1-1: World Market for Vaccines, by Type, 2001-2010

Figure 1-2: World Market for Vaccines, by Type, 2001, 2005 and 2010

Table 1-3: Major Manufacturer’s Shares of the World Vaccine Market 2003

Figure 1-3: World Vaccines Market Share by Leading Competitors 2003

Chapter Two: Introduction to Vaccines

Table 2-1: Impact of Vaccines in the 20th Century

Table 2-2: Vaccine-Preventable Diseases

Chapter Three: Pediatric Preventive Vaccines

Table 3-1: Global Immunization Score Card: Percentage of Countries and Population Left to Reach by WHO Objective

Table 3-2: Immunization Profile of the United States

Table 3-3: U.S. Recommended Childhood Immunization Schedule, July through December 2004

Table 3-4: Cost of Vaccines:  Private Sector Versus Public Sector: Prices Last Reviewed/Updated, August 2004

Table 3-5: Selected Pediatric Vaccines in Development

Table 3-6: World Market for Pediatric Vaccines by Type 2001-2010

Figure 3-1: Market Share of Pediatric Vaccines by Type 2004

Figure 3-2: Market Share of Pediatric Vaccines by Type 2010

Table 3-7: World DTP and DTaP Vaccine Market 2001-2010

Table 3-8: World Pediatric Hepatitis Vaccine Market 2001-2010

Table 3-9: World Hib Vaccine Market, 2001-2010

Table 3-10: World MMR Vaccines Market 2001-2010

Table 3-11: World Combination Vaccines Market 2001-2010

Table 3-12: World Pediatric Pneumococcal Vaccine Market 2001-2010

Table 3-13: World Poliovirus Vaccine Market 2001-2010

Table 3-14: World Varicella Vaccine Market 2001-2010

Table 3-15: World Travel & Other Vaccines Market 2001-2010

Chapter Four: Adult Preventive Vaccines

Table 4-1: Low Adult Vaccination: A Costly Heath care Burden Number of Vaccine-Preventable Deaths in the United States vs Five Other Causes

Table 4-2: Universal Adult Immunization Schedule 2004

Table 4-3: Adult Immunization Schedule for Populations with Special Medical Conditions, 2004

Table 4-4: Selected Adult Preventive Vaccines in Development, 2004

Table 4-5: World Market for Adult Preventive Vaccines, 2001-2010

Figure 4-1: Market Share of Adult Vaccines, by Type, 2004

Figure 4-2: Market Share of Adult Vaccines, by Type, 2010

Table 4-6: World Hepatitis Vaccine Market 2001-2010

Table 4-8: World Influenza Vaccine Market 2001-2010

Figure 4-3: Immunization Rates of Persons Receiving  Influenza Vaccine in 2002 by Age Group

Table 4-8: CDC Goal to Double Flu Immunization by 2010

Table 4-9: 2003 Estimated Population by Region and Selected Age Group

Table 4-10: World Pneumococcal Vaccine Market 2001-2010

Figure 4-5: European 65+ Population:  Percent by Country

Table 4-11: World Travel; Diphtheria-Tetanus;  Miscellaneous Vaccines Market 2001-2010

Chapter Five: Preventive Vaccines Market Summary

Table 5-1: The World Vaccines Market by Vaccine Type 2001-2010

Figure 5-1: World Market for Vaccines by Type 2001-2010

Figure 5-2: World Market for Vaccines Share by Type, 2001, 2005 and 2010

Table 5-2: Major Manufacturer’s Shares of the World Vaccine Market, 2003

Figure 5-3: 2003 World Vaccines Market Share, by Leading Competitors

Figure 5-4: Global Market Share of Leading Competitors by Region, 2003

Table 5-3: Major Manufacturer’s Shares of the  World Pediatric Vaccine Market 2003

Figure 5-5: Market Share of Pediatric Vaccines Market, 2003

Table 5-4: Major Manufacturer’s Shares of the  World Adult Vaccine Market 2003

Figure 5-6: Market Share of Adult Vaccines Market 2003

Chapter Six: Therapeutic Cancer Vaccines

Table 6-1: Estimated and Projected World Cancer Incidence by Common Type of Cancer, 2003 and 2020

Figure 6-1: Estimated and Projected World Cancer Incidence by Common Type of Cancer, 2003 and 2020

Table 6-2: Estimated and Projected World Cancer Mortality by Common Type of Cancer, 2003 and 2020

Figure 6-2: Estimated and Projected World Cancer Mortality by Common Type of Cancer, 2003 and 2020

Table 6-3: Cancer Vaccines in the Pipeline

Table 6-4: World Market Cancer Vaccines by  Current and Emerging Markets 2001-2008

Figure 6-3: Cancer Vaccines by Current and Emerging Market Revenues and Percent Distribution, 2001-2008

Chapter Seven: Issues and Trends

Table 7-1: Impact of Vaccines in the 20th Century

Table 7-2: Tailored Products: Divergence of Vaccine Products Between Industrialized and Developing Countries

Table 7-3: Selected Companies/Laboratories Developing Biodefense Vaccines

Appendix A: Vaccine Products

Table A-1: Selected Vaccines Currently Available Worldwide

Table A-2: Vaccines Licensed for Immunizations and Distributed in the United States as of January 2004

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Neurologic Cancers: Selections from “The World Market for Neurotherapeutic Drugs”

    $1,121.00 – $1,717.00
  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The

    $3,500.00 – $7,000.00
  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures,...U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey,...
Scroll to top